Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2022 | 1 |
2023 | 1 |
2024 | 1 |
2025 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
WNT5a Signaling through ROR2 Activates the Hippo Pathway to Suppress YAP1 Activity and Tumor Growth.
Cancer Res. 2023 Apr 4;83(7):1016-1030. doi: 10.1158/0008-5472.CAN-22-3003.
Cancer Res. 2023.
PMID: 36622276
Free PMC article.
AKT Inhibition Sensitizes to Polo-Like Kinase 1 Inhibitor Onvansertib in Prostate Cancer.
Nouri M, Varkaris A, Ridinger M, Dalrymple SL, Dennehy CM, Isaacs JT, Einstein DJ, Brennen WN, Balk SP.
Nouri M, et al.
Mol Cancer Ther. 2024 Oct 1;23(10):1404-1417. doi: 10.1158/1535-7163.MCT-23-0933.
Mol Cancer Ther. 2024.
PMID: 38894678
Item in Clipboard
Invariant NKT cell-augmented GM-CSF-secreting tumor vaccine is effective in advanced prostate cancer model.
Varghese B, Lynch L, Vriend LE, Draganov D, Clark JM, Kissick HT, Varghese S, Sanda MG, Dranoff G, Arredouani MS, Balk SP, Exley MA.
Varghese B, et al.
Cancer Immunol Immunother. 2022 Dec;71(12):2943-2955. doi: 10.1007/s00262-022-03210-8. Epub 2022 May 6.
Cancer Immunol Immunother. 2022.
PMID: 35523889
Free PMC article.
Item in Clipboard
Cite
Cite
ARTICLE TYPE
ARTICLE LANGUAGE
AGE
Filters on the sidebar will be reset to the default list and any currently applied filters will be cleared.